L-Carnosine for Bipolar I Disorder

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Bipolar I Disorder
Interventions
DRUG

L-carnosine

an antioxidant and AGE inhibitor, 500 mg/day, increasing each week in titration reaching 2000 mg/day in 4 weeks and maintained for rest of trial

Trial Locations (3)

15017

Mayview State Hospital, Bridgeville

15132

Mon-Yough Community Services, Inc., McKeesport

15213

Western Psychiatric Institute and Clinic, Pittsburgh

All Listed Sponsors
collaborator

National Alliance for Research on Schizophrenia and Depression

OTHER

lead

University of Pittsburgh

OTHER

NCT00177463 - L-Carnosine for Bipolar I Disorder | Biotech Hunter | Biotech Hunter